Reply S.p.A. (LON:0RV0)

Theseus Pharmaceuticals Revenue

Reply had revenue of 610.43M EUR in the quarter ending June 30, 2025, with 9.00% growth. This brings the company's revenue in the last twelve months to 2.43B, up 9.54% year-over-year. In the year 2024, Reply had annual revenue of 2.33B with 8.75% growth.

• Revenue (ttm): 2.43B EUR
• Revenue Growth: +9.54%
• P/S Ratio: 2.06
• Revenue / Employee: 155.03K EUR
• Employees: 15,667
• Market Cap: 4.28B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.33B	187.46M	8.75%
Dec 31, 2023	2.14B	231.36M	12.11%
Dec 31, 2022	1.91B	409.13M	27.25%
Dec 31, 2021	1.50B	231.84M	18.26%
Dec 31, 2020	1.27B	63.91M	5.30%